AIMEE S WEISNER

CIK 1227308 · CVP, General Counsel · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.10M

Companies

5

Total Filings

56

Lifetime Open-Market Net

-$4.37M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LNSR Director 110,368 $5.82 $642.3K $131.3K 10 2026-06-05
GKOS Director 22,684 $126.81 $2.88M -$4.67M 25 2026-06-01
STAA Director 15,352 $28.37 $435.5K $164.1K 7 2024-06-24
Oyster Point Pharma, Inc. (OYST) Delisted Director 3,573 $11.17 $39.9K $0 5 2023-01-04
EW CVP, General Counsel 1,675 $85.11 $142.6K $0 3 2012-05-11

Recent Filings · Page 4 of 6

56 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-07 GKOS Grant (A) +2,382 $0 EDGAR
2021-05-20 LNSR Grant (A) $0 EDGAR
2021-03-16 LNSR Grant (A) $0 EDGAR
2021-02-02 LNSR Grant (A) $0 EDGAR
2021-01-06 GKOS Grant (A) +980 $0 EDGAR
2020-06-10 Oyster Point Pharma, Inc. (OYST) Delisted Grant (A) +6,600 $0 EDGAR
2020-06-05 GKOS Grant (A) +3,900 $0 EDGAR
2020-01-03 GKOS Grant (A) +1,162 $0 EDGAR
2019-11-04 Oyster Point Pharma, Inc. (OYST) Delisted Grant (A) +23,125 $0 EDGAR
2019-05-31 GKOS Grant (A) +2,653 $0 EDGAR
Showing 3140 of 56
Page 4 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.